CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
97 hedge funds and large institutions have $192M invested in Concert Pharmaceuticals, Inc. in 2016 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less capital invested
Capital invested by funds: $264M → $192M (-$71.5M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
97
Holding in Top 10
2
Calls
$21K
Puts
$6K
Top Buyers
| 1 | +$7.15M | |
| 2 | +$4.79M | |
| 3 | +$1.46M | |
| 4 |
AIC
AWM Investment Company
New York
|
+$1.37M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.28M |
Top Sellers
| 1 | -$4.75M | |
| 2 | -$3.43M | |
| 3 | -$3.42M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$1.75M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.43M |